Shuhei Yamada

Phase II Trial of Trastuzumab and Docetaxel in Patients With Human Epidermal Growth Factor Receptor 2–Positive Salivary Duct Carcinoma

Hideaki Takahashi, Yuichiro Tada, Takashi Saotome et al. · Journal of Clinical Oncology · 2018 · 256 citations

Medicine, Oncology, Pharmacology +15

Onsite survey on the mechanism of passive aeration and air flow path in a semi-aerobic landfill

Toshihiko Matsuto, Xin Zhang, Takayuki Matsuo et al. · Waste Management · 2014 · 56 citations · Full text

Engineering, Environmental Engineering, Environmental Sciences +17

Prospective evaluation of incidence and severity of oral mucositis induced by conventional chemotherapy in solid tumors and malignant lymphomas

Noriko Nishimura, Kenji Nakano, Kyoko Ueda et al. · Supportive Care in Cancer · 2011 · 52 citations

Pharmacy, Oncology, Chemotherapy +15

Bone metastasis and poor performance status are prognostic factors for survival of carcinoma of unknown primary site in patients treated with systematic chemotherapy

Makoto Kodaira, Shunji Takahashi, Shuhei Yamada et al. · Annals of Oncology · 2009 · 34 citations

Medicine, Oncology, Surgery +14

Successful treatment of histiocytic sarcoma with induction chemotherapy consisting of dose-escalated CHOP plus etoposide and upfront consolidation auto-transplantation

Hideki Tsujimura, Toshiko Miyaki, Shuhei Yamada et al. · International Journal of Hematology · 2014 · 29 citations

Medicine, Oncology, Chemotherapy +2